UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
This deal makes Meddo, one of the largest health-tech players in India
The company's operating revenue for Q4 FY21 was Rs. 330.2 crore
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
Subscribe To Our Newsletter & Stay Updated
